Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 1;4(9):e2126114.
doi: 10.1001/jamanetworkopen.2021.26114.

Trends in Outpatient Antibiotic Prescriptions in the United States During the COVID-19 Pandemic in 2020

Deanna J Buehrle  1 , Marilyn M Wagener  2 , M Hong Nguyen  2 , Cornelius J Clancy  1   2
Affiliations

Trends in Outpatient Antibiotic Prescriptions in the United States During the COVID-19 Pandemic in 2020

Deanna J Buehrle et al. JAMA Netw Open. .

Abstract

This cross-sectional study examines the prescription fills of commonly prescribed outpatient antibiotics in the US through the end of 2020.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Nguyen reported receiving grants from Astellas, Merck, Melinta, and Cidara outside the submitted work and reported serving on advisory boards for Astellas, Merck, the Medicines Company, Scynexis, and Shionogi. Dr Clancy reported receiving grants from Astellas, Merck, Melinta, and Cidara outside the submitted work, serving on advisory boards or consulting for Astellas, Merck, the Medicines Company, Cidara, Scynexis, Shionogi, Qpex, and Needham and Company, and being a speaker at a symposium sponsored by Merck and T2Biosystems. Dr Buehrle reported serving on an advisory board for Shionogi outside the submitted work. No other disclosures were reported.

Figures

Figure.
Figure.. Outpatient Antibiotic Prescription Fills in the United States, January 2015 Through December 2020
Data are for 9 of the 10 most commonly prescribed outpatient antibiotics in the United States, excluding sulfamethoxazole-trimethoprim (for which complete 2020 data were unavailable). The beginning of the COVID-19 pandemic nationally is taken to be March 2020. Monthly prescription fill data are presented as filled black circles. Prescription fill data are from IQVIA National Prescription Audit databases, which project total retail prescription drug sales using information from over 93% of retail pharmacies in the US. The data include prescriptions for adults or children stemming from encounters in any setting, including in-person and telemedicine visits, and from telephone or electronic communications. Population data are taken from US Census monthly estimates.
See this image and copyright information in PMC

References

    1. Buehrle DJ, Nguyen MH, Wagener MM, Clancy CJ. Impact of the coronavirus disease 2019 pandemic on outpatient antibiotic prescriptions in the United States. [published online December 22, 2020]. Open Forum Infect Dis. 2020;7(12):a575. doi:10.1093/ofid/ofaa575 - DOI - PMC - PubMed
    1. Buehrle DJ, Wagener MM, Clancy CJ. Outpatient fluoroquinolone prescription fills in the United States, 2014 to 2020: assessing the impact of Food and Drug Administration safety warnings. Antimicrob Agents Chemother. 2021;65(7):e0015121. doi:10.1128/AAC.00151-21 - DOI - PMC - PubMed
    1. Tran PT, Antonelli PJ, Hincapie-Castillo JM, Winterstein AG. Association of US Food and Drug Administration removal of indications for use of oral quinolones with prescribing trends. [published online April 19, 2021]. JAMA Intern Med. 2021;181(6):808-816. doi:10.1001/jamainternmed.2021.1154 - DOI - PMC - PubMed
    1. Centers for Disease Control and Prevention . Reduced Access to Care: Household Pulse Survey. https://www.cdc.gov/nchs/covid19/pulse/reduced-access-to-care.htm. Accessed April 22, 2021.
    1. Metlay JP, Waterer GW, Long AC, et al. . Diagnosis and treatment of adults with community-acquired pneumonia. an official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200(7):e45-e67. doi:10.1164/rccm.201908-1581ST - DOI - PMC - PubMed

Substances